Rexford Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Rexford Capital's LLY Position: Q1 2026 in Review
Rexford Capital increased its Eli Lilly (LLY) stake by 4.3% in Q1 2026, buying an estimated $68.9K and bringing the position to 1,656 shares worth $1.52M. The position accounts for 1.09% of the portfolio, ranked #20.
Rexford Capital first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.71M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Rexford Capital held 1,656 shares of Eli Lilly worth $1.52M as of Q1 2026.
- Rexford Capital bought 68 Eli Lilly shares in Q1 2026, an estimated $68.9K.
- Eli Lilly made up 1.09% of Rexford Capital's portfolio in Q1 2026, its #20 holding.
- Rexford Capital first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
- Rexford Capital's Eli Lilly position peaked at $1.71M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Rexford Capital's 13F filing for Q1 2026, filed 24 Apr 2026.